A comparison of the embryonic stem cell test and whole embryo culture assay combined with the BeWo placental passage model for predicting the embryotoxicity of azoles

Toxicol Lett. 2018 Apr:286:10-21. doi: 10.1016/j.toxlet.2018.01.009. Epub 2018 Jan 11.

Abstract

In the present study, we show the value of combining toxico-dynamic and -kinetic in vitro approaches for embryotoxicity testing of azoles. Both the whole embryo culture (WEC) and the embryonic stem cells test (EST) predicted the in vivo potency ranking of twelve tested azoles with moderate accuracy. Combining these results with relative placental transfer rates (Papp values) as determined in the BeWo cell culture model, increased the predictability of both WEC and EST, with R2 values increasing from 0.51 to 0.87 and from 0.35 to 0.60, respectively. The comparison of these in vitro systems correlated well (R2 = 0.67), correctly identifying the in vivo strong and weak embryotoxicants. Evaluating also specific gene responses related with the retinoic acid and sterol biosynthesis pathways, which represent the toxicological and fungicidal mode of action of azoles respectively in the WEC and EST, we observed that the differential regulation of Dhrs3 and Msmo1 reached higher magnitudes in both systems compared to Cyp26a1 and Cyp51. Establishing sensitive biomarkers across the in vitro systems for studying the underlying mechanism of action of chemicals, such as azoles, is valuable for comparing alternative in vitro models and for improving insight in the mechanism of developmental toxicity of chemicals.

Keywords: Azoles; Biomarkers; Embryotoxicity; Placental transfer; Stem cell test; Whole embryo culture.

Publication types

  • Comparative Study

MeSH terms

  • Alcohol Oxidoreductases / genetics
  • Alcohol Oxidoreductases / metabolism
  • Animals
  • Azoles / toxicity*
  • Biological Assay*
  • Biological Transport
  • Cell Differentiation / drug effects
  • Cell Line
  • Dose-Response Relationship, Drug
  • Embryo Culture Techniques
  • Embryo, Mammalian / drug effects*
  • Embryo, Mammalian / metabolism
  • Embryo, Mammalian / pathology
  • Female
  • Gene Expression Regulation, Developmental / drug effects
  • Humans
  • Kinetics
  • Mice
  • Mixed Function Oxygenases / genetics
  • Mixed Function Oxygenases / metabolism
  • Mouse Embryonic Stem Cells / drug effects*
  • Mouse Embryonic Stem Cells / metabolism
  • Mouse Embryonic Stem Cells / pathology
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / metabolism
  • Myocytes, Cardiac / pathology
  • Placenta / drug effects*
  • Placenta / metabolism
  • Placenta / pathology
  • Pregnancy
  • Reproducibility of Results
  • Retinoic Acid 4-Hydroxylase / genetics
  • Retinoic Acid 4-Hydroxylase / metabolism
  • Risk Assessment
  • Sterol 14-Demethylase / genetics
  • Sterol 14-Demethylase / metabolism
  • Teratogens / toxicity*
  • Toxicity Tests / methods*

Substances

  • Azoles
  • Teratogens
  • Mixed Function Oxygenases
  • Alcohol Oxidoreductases
  • DHRS3 protein, mouse
  • Cyp26a1 protein, mouse
  • Retinoic Acid 4-Hydroxylase
  • Cyp51 protein, mouse
  • Sterol 14-Demethylase
  • methylsterol monooxygenase